Related Experiment Video

Updated: Jun 2, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Vagal nerve stimulation in prevention and management of coronary heart disease

Undurti N Das1

  • 1Undurti N Das, UND Life Sciences, 13800 Fairhill Road, #321, Shaker Heights, OH 44120, United States. undurti@hotmail.com

World Journal of Cardiology
|April 29, 2011
PubMed

Insights

Vagal nerve stimulation may prevent coronary heart disease (CHD) and arrhythmias by reducing inflammation. Measuring specific molecules and vagal tone can aid in predicting, preventing, and managing CHD.

Area of Science:

  • Cardiovascular Science
  • Neuroimmunology

Background:

  • Coronary heart disease (CHD) and atherosclerosis are linked to chronic low-grade systemic inflammation.
  • Congestive cardiac failure and arrhythmias contribute significantly to CHD mortality.
  • Vagal stimulation exhibits anti-inflammatory properties, potentially mitigating these conditions.

Purpose of the Study:

  • To explore the anti-inflammatory and anti-arrhythmic roles of vagal neurotransmitters and polyunsaturated fatty acids (PUFAs) in CHD.
  • To investigate the potential of vagal nerve stimulation in preventing CHD and cardiac arrhythmias.

Main Methods:

  • Review of the literature on the interplay between vagal stimulation, acetylcholine, PUFAs, and inflammatory pathways.
  • Discussion of potential biomarkers for CHD and arrhythmia prediction and management.

Main Results:

  • Acetylcholine, the primary vagal neurotransmitter, possesses potent anti-inflammatory effects.
  • Polyunsaturated fatty acids (PUFAs) enhance acetylcholine release and are precursors to anti-inflammatory and anti-arrhythmic molecules.
  • Reduced PUFA levels are observed in patients with CHD and atherosclerosis.

Conclusions:

  • Vagal nerve stimulation is a promising strategy for the prevention of CHD and cardiac arrhythmias.
  • Measuring specific molecules (catecholamines, acetylcholine, PUFAs, and their metabolites) and assessing vagal tone (heart rate variability) can aid in CHD prediction, prevention, and management.

Keywords:
AcetylcholineCardiac arrhythmiasCoronary heart diseaseHeart failureVagal nerve stimulation

More Related Videos

Implantation Surgery for Abdominal Vagus Nerve Stimulation and Recording Studies in Awake Rats07:17

Implantation Surgery for Abdominal Vagus Nerve Stimulation and Recording Studies in Awake Rats

Published on: January 19, 2024

Preparation of Peripheral Nerve Stimulation Electrodes for Chronic Implantation in Rats09:39

Preparation of Peripheral Nerve Stimulation Electrodes for Chronic Implantation in Rats

Published on: July 14, 2020

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...